The province is taking urgent action to ensure all cystic fibrosis patients will have more timely access to the effective and lifechanging treatments they need. Ontario is now providing coverage for Trikafta, the latest and most effective treatment option for cystic fibrosis to become available, under its publicly-funded drug program to give patients more access to lifechanging treatments for cystic fibrosis.
Providing coverage for Trikafta is one more way our government is building a sustainable, modern and connected health care system that will expand coverage to new and innovative treatments and provide high-quality health care to patients for years to come.
Applying to the Exceptional Access Program
- English: https://www.ontario.ca/page/applying-exceptional-access-program
- French: https://www.ontario.ca/fr/page/faire-une-demande-au-programme-dacces-exceptionnel